Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab

about

Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab

Item

http://www.wikidata.org/entity/Q58130125

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Serum cytokine levels in breas ...... ant treatment with bevacizumab

@en

Serum cytokine levels in breas ...... ant treatment with bevacizumab

@nl

type

Item

label

Serum cytokine levels in breas ...... ant treatment with bevacizumab

@en

Serum cytokine levels in breas ...... ant treatment with bevacizumab

@nl

prefLabel

Serum cytokine levels in breas ...... ant treatment with bevacizumab

@en

Serum cytokine levels in breas ...... ant treatment with bevacizumab

@nl

P1476

Serum cytokine levels in breas ...... ant treatment with bevacizumab

@en

P2093

Hedda von der Lippe Gythfeldt

http://www.w3.org/2001/XMLSchema#string

Jon Amund Kyte

http://www.w3.org/2001/XMLSchema#string

Marianne Nome

http://www.w3.org/2001/XMLSchema#string

Olav Engebraaten

http://www.w3.org/2001/XMLSchema#string

Ruth Dannenfelser

http://www.w3.org/2001/XMLSchema#string

Shakila Jabeen

http://www.w3.org/2001/XMLSchema#string

Surendra Kumar

http://www.w3.org/2001/XMLSchema#string

Torben Lüders

http://www.w3.org/2001/XMLSchema#string

Xavier Tekpli

http://www.w3.org/2001/XMLSchema#string

P2860

Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver

Advanced Hepatocellular Carcinoma: Early Evaluation of Response to Bevacizumab Therapy at Dynamic Contrast-enhanced US with Quantification—Preliminary Results 1

Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function

Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

Th1/Th2 cells

Safety of bevacizumab in patients with advanced cancer: a meta-analysis of randomized controlled trials.

IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions.

Transcription factor regulation can be accurately predicted from the presence of target gene signatures in microarray gene expression data.

Bevacizumab increases risk for severe proteinuria in cancer patients.

P304

e1457598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2018.1457598

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anne-Lise Børresen-Dale

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30377556

http://www.w3.org/2001/XMLSchema#string

P921

immunology

bevacizumab

P932

6205029

http://www.w3.org/2001/XMLSchema#string